| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
+ 1 more risk
Jia Jie Biomedical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$20.25 |
| 52 Week High | NT$27.80 |
| 52 Week Low | NT$13.00 |
| Beta | 0.52 |
| 1 Month Change | -20.12% |
| 3 Month Change | -8.99% |
| 1 Year Change | 35.00% |
| 3 Year Change | 39.66% |
| 5 Year Change | -11.57% |
| Change since IPO | 55.63% |
Recent News & Updates
Shareholder Returns
| 4109 | TW Personal Products | TW Market | |
|---|---|---|---|
| 7D | 0% | -0.2% | 0.6% |
| 1Y | 35.0% | -10.5% | 29.2% |
Return vs Industry: 4109 exceeded the TW Personal Products industry which returned -10.5% over the past year.
Return vs Market: 4109 exceeded the TW Market which returned 29.2% over the past year.
Price Volatility
| 4109 volatility | |
|---|---|
| 4109 Average Weekly Movement | 6.9% |
| Personal Products Industry Average Movement | 4.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in TW Market | 8.6% |
| 10% least volatile stocks in TW Market | 2.3% |
Stable Share Price: 4109's share price has been volatile over the past 3 months.
Volatility Over Time: 4109's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | n/a | Wen-Fang Hsieh | www.jiajiebio.com |
Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules; and import and export, distribution, bidding, quotation of the products. It is also involved in the wholesale of nonalcoholic beverages, candy, baked food, supplementary food, groceries, daily commodities, and cosmetics; production of water purification equipment and related parts; life and property insurance brokerage business; development and production of aquatic product technology; and development of biological products.
Jia Jie Biomedical Co., Ltd. Fundamentals Summary
| 4109 fundamental statistics | |
|---|---|
| Market cap | NT$2.00b |
| Earnings (TTM) | NT$180.24m |
| Revenue (TTM) | NT$414.51m |
11.1x
P/E Ratio4.8x
P/S RatioIs 4109 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4109 income statement (TTM) | |
|---|---|
| Revenue | NT$414.51m |
| Cost of Revenue | NT$278.22m |
| Gross Profit | NT$136.29m |
| Other Expenses | -NT$43.95m |
| Earnings | NT$180.24m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.83 |
| Gross Margin | 32.88% |
| Net Profit Margin | 43.48% |
| Debt/Equity Ratio | 3.4% |
How did 4109 perform over the long term?
See historical performance and comparison